Evidence map›Paper›PMID 28153846›Full record

ArticleDisease models & mechanisms2017

Miconazole protects blood vessels from MMP9-dependent rupture and hemorrhage.

Ran Yang, Yunpei Zhang, Dandan Huang, Xiao Luo, Liangren Zhang, Xiaojun Zhu, Xiaolin Zhang, Zhenming Liu, Jing-Yan Han, Jing-Wei Xiong

Open access · goldAbstract read
In one paragraph

Article in Disease models & mechanisms, 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 16 papers.

0numbers the graph read from it
0cells of the map it votes in
16citing papers in PubMed
1.8field-weighted citation impact, top 16% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

16 citing papers in PubMed, 27 citations in OpenAlex.

  1. GlialeLife · 2026
    Article
  2. Review
  3. Article
  4. Article
  5. Review
  6. Miconazole-like Scaffold is a Promising Lead forJournal of medicinal chemistry · 2023
    Article
  7. Article
  8. Study on potential differentially expressed genes in stroke by bioinformatics analysis.Neurological sciences : official journal of the Italian Neurological Society and of the Italian Society of Clinical Neurophysiology · 2022
    Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. Article
  14. Review
  15. Article
  16. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors at 2 institutions in 1 country.

Ran YangBeijing Key Laboratory of Cardiometabolic Molecular Medicine, Institute of Molecular Medicine, Peking University, Beijing 100871, China.
Yunpei ZhangDepartment of Integration of Chinese and Western Medicine, School of Basic Medical Sciences, Peking University, Beijing 100191, China.
Dandan HuangDepartment of Integration of Chinese and Western Medicine, School of Basic Medical Sciences, Peking University, Beijing 100191, China.
Xiao LuoState Key Laboratory of Natural and Biomimetic Drugs, School of Pharmaceutical Sciences, Peking University, Beijing 100871, China.
Liangren ZhangState Key Laboratory of Natural and Biomimetic Drugs, School of Pharmaceutical Sciences, Peking University, Beijing 100871, China.
Xiaojun ZhuBeijing Key Laboratory of Cardiometabolic Molecular Medicine, Institute of Molecular Medicine, Peking University, Beijing 100871, China.
Xiaolin ZhangAstraZeneca Asia and Emerging Market Innovative Medicine and Early Development, Shanghai 201203, China.
Zhenming LiuState Key Laboratory of Natural and Biomimetic Drugs, School of Pharmaceutical Sciences, Peking University, Beijing 100871, China jingwei_xiong@pku.edu.cn hanjingyan@bjmu.edu.cn zmliu@bjmu.edu.cn.
Jing-Yan HanDepartment of Integration of Chinese and Western Medicine, School of Basic Medical Sciences, Peking University, Beijing 100191, China jingwei_xiong@pku.edu.cn hanjingyan@bjmu.edu.cn zmliu@bjmu.edu.cn.
Jing-Wei XiongBeijing Key Laboratory of Cardiometabolic Molecular Medicine, Institute of Molecular Medicine, Peking University, Beijing 100871, China jingwei_xiong@pku.edu.cn hanjingyan@bjmu.edu.cn zmliu@bjmu.edu.cn.ORCID 0000-0001-8438-4782
Peking University · CNShanghai Innovative Research Center of Traditional Chinese Medicine · CN

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Hemorrhagic stroke accounts for 10-15% of all strokes and is strongly associated with mortality and morbidity worldwide, but its prevention and therapeutic interventions remain a major challenge. Here, we report the identification of miconazole as a hemorrhagic suppressor by a small-molecule screen in zebrafish. We found that a hypomorphic mutant

Indexed as

AnimalsBlood VesselsCerebral HemorrhageDisease Models, AnimalDrug Evaluation, PreclinicalExtracellular MatrixMAP Kinase Signaling SystemMatrix Metalloproteinase 9MiconazoleMutationRuptureStrokeUrokinase-Type Plasminogen ActivatorZebrafishMatrix Metalloproteinase 9MiconazoleUrokinase-Type Plasminogen ActivatorChemical screenHemorrhageMiconazoleMmp9StrokeZebrafish

Identifiers

PMID28153846
PMCPMC5374319
OpenAlexW2585746540

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.